A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

NCT00356681 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

282

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to close study

Conditions

Breast Neoplasms
Breast Tumors
Breast Cancer
Locally Recurrent and Metastatic Breast Cancer

Interventions

DRUG: AMG 706 placebo
DRUG: Bevacizumab
DRUG: AMG 706
DRUG: Paclitaxel

Sponsor

Amgen